Beyond consent: Ethical and social issues in genetic testing

Nature Reviews Genetics

Volumn 2, Issue 2, 2001, Pages 147-151

  Burgess, Michael M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENETIC SCREENING; GENETICS AND REPRODUCTION; HUMAN; INFORMED CONSENT; MEDICAL ETHICS;

GENETICS AND REPRODUCTION;

ETHICS, MEDICAL; GENETIC SCREENING; HUMANS; INFORMED CONSENT;

EID: 0035259897     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/35052579     Document Type: Review

References (46)

1. Rapp, R. Chromosomes and communication: the discourse of genetic counselling. Med. Anthrop. Quart. 2, 143-157 (1988).
2. Lippman, A. in The Future of Human Reproduction (ed. Overall, C.) 182-194 (The Women's Press, Toronto, 1989).
3. Clarke, A. Is non-directive genetic counselling possible? Lancet 338, 998-1001 (1991).
4. Farrer, L. A. Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk. Am. J. Med. Genet. 24, 305-3111 (1986).
5. Kessler, S. & Bloch, M. Social system responses to Huntington disease. Family Processes 28, 59-68 (1989).
6. Fox, S., Bloch, M., Fahy, M. & Hayden, M. R. Predictive testing for Huntington disease: description of a pilot study in British Columbia. Am. J. Med. Genet. 32, 211-216 (1988).
7. Benjamin, C. M. et al. and the Canadian collaborative groups for predictive testing for Huntington disease. Proceed with care: direct predictive testing for Huntington disease. Am. J. Hum. Genet. 55, 606-617 (1994).
8. Quaid, K. A. Presymptomatic testing for Huntington disease: recommendations for counselling. Am. J. Med. Genet. 39, 347-354 (1992).
9. Biesecker, B. B. & Marteau, T. M. The future of genetic counselling: an international perspective. Nature Genet. 22, 133-137 (1999).
10. DeGrazia, D. The ethical justification for minimal paternalism in the use of the predictive test for Huntington's disease. J. Clin. Ethics 2, 219-228 (1991).
11. Burgess, M. M. & Hayden, M. R. Patients' rights to laboratory data: trinucleotide repeat length in Huntington disease. Am. J. Med. Genet. 162, 6-9 (1996).
12. Koenig, B. et al. Genetic testing for BRCA1 and BRCA2: recommendations of the Stanford program in genomics, ethics and society. J. Women's Health 7, 531-545 (1998).
13. Kerr, A. & Cunningham-Burley, S. On ambivalence and risk: reflexive modernity and the new human genetics. Sociology 34, 283-304 (2000).
14. Burgess, M. M. in The Commercialization of Genetics Research: Ethical, Legal, and Policy Issues (eds Caulfield, T. A. & Williams-Jones, B.) 181-194 (Kluwer Academic/Plenum Publishers, New York, 1999).
15. Nelkin, D. & Lindee, M. S.. The DNA Mystique: The Gene as a Cultural Icon (New York: Freeman, 1995).
16. Harper, P. S. Direct marketing of cystic fibrosis carrier screening: commercial push or population need? J. Med. Genet. 32, 249-250 (1995).
17. Huggins, M. et al. Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk. Am. J. Med. Genet. 42, 508 (1992).
18. Vineis, P. & Schulte, P. A. Scientific and ethical aspects of genetic screening of workers for cancer risk: the case of N-acetyltransferase phenotype. J. Clin. Epidemiol. 48, 189-197 (1995).
19. MacDonald, C. & Williams-Jones, B. Ethics and genetics: susceptibility testing in the workplace. J. Business Ethics (submitted).
20. Lemmens, T. What about your genes? Ethical, legal and policy dimensions of genetics in the workplace. Politics and the Life Sciences 16, 57-75 (1997).
21. Working Group on Ethical, Legal and Social Implications of Human Genome Research. Genetic Information and Health Insurance. Report of the Task Force: (National Institutes of Health, Bethesda, Maryland, 1993).
22. Abbott, A. Israel split on rights to genetic privacy. Nature 394, 214 (1998).
23. McGleenan, T., Weising, U. & Ewald, F. (eds) Genetics and Insurance (Springer, New York, 1999).
24. NIH-DOE Working Group on Ethical, Legal, and Social Implications of Human Genome Research. Genetic Information and Health Insurance (Human Genome Project, Washington DC, 1993).
25. Lemmens, T. & Bahamin, P. in Socio-Ethical Issues in Human Genetics (ed. Knoppers, B. M.) 115-275 (Les Editions Yvons-Blais Inc., Cowansville, Quebec, 1998).
26. Greely, H. T. in The Code of Codes: Scientific and Social Issues in the Human Genome Project (eds Kelves, D. J. & Hood, L.) 274-280 (Harvard Univ. Press, Cambridge, Massachusetts, 1992).
27. McGleenan, T. & Wiesing, U. in Genetics and Insurance (eds McGleenan, T. et al.) 116-117 (Springer, New York, 1999).
28. Murray, T. Genetics and the moral mission of health insurance. Hastings Center Report 22, 12-15 (1992).
29. Wilkie, T. Genetics and insurance in Britain: why more than just the Atlantic divides the English-speaking nations. Nature Genet. 20, 119-121 (1998).
30. Dutch Health Council. Genetics, Science & Society (Dutch Health Council, The Hague, 1989).
31. Sandberg, P. Genetic information and life insurance: a proposal for an ethical European policy. Social Sci. Med. 40, 1549-1559 (1995).
32. Collins, F. cited in Wadman, M. News: Jewish leaders meet NIH chiefs on genetic stigmatisation fears. Nature 392, 851 (1998).
33. Editorial. Privacy matters. Nature Genet. 19, 207-208 (1998).
34. Weijer, C., Goldsand, G. & Emanuel, E. J. Protecting communities in research: current guidelines and limits of extrapolation. Nature Genet. 23, 275-280 (1999).
35. Weijer, C. Protecting communities in research: Philosophical and pragmatic challenges. Cam. Q. Health Ethics 8, 501-513 (1999).
36. Burgess, M. M. & Brunger, F. in The Governance of Health Research involving Human Subjects (ed. McDonald, M.) 141-175 (Law Commission of Canada, Ottawa, 2000). Also see http://www.lcc.gc. ca/en/themes/gr/hrish/macdonald/macdonald.pdf
37. Foster, M. W., Berensten, D. & Carter, T. H., A model agreement for genetic research in socially identifiable populations. Am. J. Hum. Genet. 63, 696-702 (1998).
38. Scheuermann, R. H. & Picker, L. J. Letter to the editor. Nature 392, 14 (1998).
39. Council for International Organizations of Medical Sciences (CIOMS) International Ethical Guidelines for Biomedical Research Involving Human Subjects (CIOMS, Geneva, 1993).
40. Weijer, C., Goldsand, G. & Emanuel, E. J. Protecting communities in research: current guidelines and limits of extrapolation. Nature Genet. 23, 275-280 (1999).
41. Burgess, M. M. & Brunger, F. in The Governance of Health Research involving Human Subjects (ed. McDonald, M.) 14-175 (Law Commission of Canada, 2000). Also see http://www.lcc.gc. ca/en/papers/macdonald/macdonald.pdf
42. Stephenson, P. in A Cross-Cultural Dialogue on Health Care Ethics (eds Coward, H. & Ratanakul, P.) 68-91. (Wilfrid Laurier Univ. Press, 1999).
43. Brunger, F. & Bassett, K. Culture and Genetics in Socioethical Issues in Human Genetics (ed. Knoppers, B. M.) 30-34 (Les Editions Won Blais Inc., Cowansville, Quebec, 1998).
44. Sclove, R. E. Democracy and Technology (The Guilford Press, New York, 1995).
45. Kerr, A., Cunningham-Burley, S. & Amos, A. The new genetics and health: Mobilizing lay expertise. Public Understanding of Science 7, 41-60 (1998).
46. Kerr, A., Cunningham-Burley, S. & Amos, A. Drawing the line: an analysis of lay people's discussions about the new genetics. Public Understanding of Science 7, 113-133 (1998).